Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

42nd Annual J.P. Morgan Healthcare Conference

Jan 11, 2024 1:30 PM EST